Achillion Pharmaceuticals (ACHN)

Create an Alert
8.01 +0.08  +1.01%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

Achillion Pharmaceuticals Revenue Quarterly:

0.00 for March 31, 2013
View Full Chart

Achillion Pharmaceuticals Revenue Quarterly Chart

    Achillion Pharmaceuticals Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.00
    Dec. 31, 2012 0.118M
    Sept. 30, 2012 0.00
    June 30, 2012 0.00
    March 31, 2012 2.489M
    Dec. 31, 2011 0.062M
    Sept. 30, 2011 0.064M
    June 30, 2011 0.056M
    March 31, 2011 0.065M
    Dec. 31, 2010 2.005M
    Sept. 30, 2010 0.17M
    June 30, 2010 0.187M
    March 31, 2010 0.074M
    Dec. 31, 2009 0.061M
    Sept. 30, 2009 -0.054M
    June 30, 2009 -0.007M
    March 31, 2009 -0.293M
    Dec. 31, 2008 -1.284M
    Sept. 30, 2008 0.025M
       
    June 30, 2008 0.398M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    ACHN Revenue Quarterly Benchmarks

    Companies
    Transcept Pharmaceuticals 0.482M
    Merrimack Pharmaceuticals 14.19M
    Vertex Pharmaceuticals 328.37M

    ACHN Revenue Quarterly Rankings

    Overall 50th percentile
    8312 of 16773
    Sector 40th percentile
    833 of 1408 in Healthcare
    Industry 45th percentile
    248 of 453 in Biotechnology

    ACHN Revenue Quarterly Range, Past 5 Years

    Minimum -1.284M Dec 2008
    Maximum 2.489M Mar 2012
    Average 0.2068M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');